Kyongbo Pharmaceutical Co., Ltd (214390.KS) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

16.4x

Market Cap

KRW 129.58B

MomentumView details →

1D Return

−2.87%

YTD Return

−6.07%

RSI (14)

56.3

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

16.4x

Market Cap

KRW 129.58B

RSI (14)

56.3

MomentumView details →

1D Return

−2.87%

YTD Return

−6.07%

ProfitabilityView details →

Gross Margin

37.24%

Net Margin

1.78%

EBITDA Margin

5.99%

ROE (TTM)

3.38%

ROA (TTM)

1.35%

Asset Turnover

0.79x

GrowthView details →

Revenue YoY

+14.83%

EPS YoY

+1166.93%

FCF YoY

−99.59%

Revenue CAGR 3Y

+10.40%

EPS CAGR 3Y

−33.55%

EBITDA YoY

−16.16%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

1.07x

Current Ratio

0.88x

Quick Ratio

0.48x

Div Yield

0.92%

Div Rate

KRW 50.00

Div Growth 1Y

+0.00%

Financials snapshotView financials →

Revenue (TTM)

279.55B

Net Income (TTM)

4.97B

Op. CF (TTM)

11.95B

Latest newsMore news →

No recent news for 214390.KS.

Similar companies

Samil Pharmaceutical Co.,Ltd000520.KS HANDOK Inc.002390.KS SAMSUNG PHARM. Co., Ltd.001360.KS Jeil Pharma Holdings Inc002620.KS Chong Kun Dang Holdings Corp.001630.KS Yuyu Pharma, Inc.000227.KS Find similar companies →

Latest newsMore news →

No recent news for 214390.KS.